FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to endocrinology, oncology, and can be used in determining a risk of progressing metabolic disorders accompanying a pancreatic tumor. That is ensured by bioimpedansometry of the ratio of total and extracellular water, basal metabolism and impedance diagram phase angle. If the content of total water increases by 15–25 % and if the phase angle is 4.4 or less, and the basic metabolism is 1,300 to 1,700 kcal, the risk of progressing metabolic disorders in pancreatic cancer is stated.
EFFECT: method provides accurate determination of the risk of progression of metabolic disorders in a pancreatic tumor by determining the ratio of certain values.
1 cl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING NON-ALCOHOLIC FATTY LIVER DISEASE AND TYPE 2 DIABETES MELLITUS | 2018 |
|
RU2706026C1 |
METHOD OF TREATING CHRONIC CONSTIPATION AND FUNCTIONAL ANOREXIA | 2013 |
|
RU2545988C1 |
METHOD FOR DETERMINING RISK OF ISCHEMIC HEART DISEASE | 2013 |
|
RU2532361C1 |
METHOD OF DIAGNOSING THE SEVERITY OF IRRITABLE BOWEL SYNDROME | 2017 |
|
RU2668496C2 |
METHOD OF LACTASE DEFICIENCY IN ADULTS TREATMENT | 2017 |
|
RU2684099C1 |
METHOD OF THE TREATMENT OF POLYNEUROPATHY ASSOCIATED WITH GLUTEN-SENSITIVE CELIAC DISEASE | 2022 |
|
RU2800847C1 |
DIAGNOSTIC TECHNIQUE FOR ASYMPTOMATIC CELIAC DISEASE IN ADULTS | 2020 |
|
RU2747523C1 |
METHOD FOR ENDOSCOPIC DISSECTION OF EPITHELIAL FORMATIONS OF THE DIGESTIVE TRACT | 2022 |
|
RU2790240C1 |
DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR HEPATIC STEATOSIS AND STEATOHEPATITIS | 2013 |
|
RU2545990C2 |
METHOD FOR ASSESSING CLINICAL EFFECTIVENESS IN IRRITABLE BOWEL SYNDROME ACCOMPANIED BY DIARRHOEA | 2014 |
|
RU2570767C1 |
Authors
Dates
2019-12-23—Published
2018-12-28—Filed